Design, Synthesis, and Biological Evaluation of Quercetagetin Analogues as JNK1 Inhibitors
The recent discovery of c-Jun NH2-terminal kinase JNK1 suppression by natural quercetagetin (1) is a promising lead for the development of novel anticancer agents. Using both X-ray structure and docking analyses we predicted that 5′-hydroxy- (2
Hierold, Judith,Baek, Sohee,Rieger, Rene,Lim, Tae-Gyu,Zakpur, Saman,Arciniega, Marcelino,Lee, Ki Won,Huber, Robert,Tietze, Lutz F.
p. 16887 - 16894
(2015/11/16)
More Articles about upstream products of 727422-83-5